We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
-23.9%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
10 Year Est. Return
AUM
$302M
AUM Growth
-$151M
Cap. Flow
-$16.4M
Cap. Flow %
-5.44%
Top 10 Hldgs %
49.77%
Holding
317
New
38
Increased
51
Reduced
65
Closed
64

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$3.72M
2
SHOP icon
Shopify
SHOP
+$3.18M
3
ADSK icon
Autodesk
ADSK
+$3.15M
4
CRM icon
Salesforce
CRM
+$2.94M
5
HTZWW
Hertz Global Holdings Warrants
HTZWW
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Healthcare 26.86%
3 Miscellaneous 22.85%
4 Communication Services 13.94%
5 Consumer Discretionary 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXY.WS icon
1
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$38.8M 12.87%
1,050,589
+9,000
+0.9% +$357K
SPOT icon
2
Spotify
SPOT
$113B
$18.4M 6.1%
196,100
+14,000
+8% +$1.58M
SHOP icon
3
Shopify
SHOP
$197B
$16.9M 5.6%
540,510
+74,510
+16% +$3.18M
SNOW icon
4
Snowflake
SNOW
$114B
$13.8M 4.57%
99,150
+23,500
+31% +$3.72M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.24T
$13M 4.3%
119,060
NET icon
6
Cloudflare
NET
$107B
$12.2M 4.06%
279,935
+14,500
+5% +$1.04M
PLTR icon
7
Palantir
PLTR
$448B
$10.8M 3.59%
1,193,000
+71,900
+6% +$711K
SE icon
8
Sea Limited
SE
$73.1B
$9.03M 2.99%
135,000
-45,746
-25% -$3.9M
ZLAB icon
9
Zai Lab
ZLAB
$2.93B
$8.61M 2.85%
248,357
+21,605
+10% +$762K
QURE icon
10
uniQure
QURE
$3.38B
$8.6M 2.85%
461,589
-31,640
-6% -$503K
MRK icon
11
Merck
MRK
$366B
$8.04M 2.66%
88,156
-10,000
-10% -$887K
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$137B
$7.89M 2.61%
28,000
HTZWW
13
Hertz Global Holdings Warrants
HTZWW
$86M
$6.87M 2.28%
701,380
+197,010
+39% +$2.55M
IONS icon
14
Ionis Pharmaceuticals
IONS
$10.1B
$6.67M 2.21%
180,107
RARE icon
15
Ultragenyx Pharmaceutical
RARE
$2.52B
$6.26M 2.07%
104,899
-7,828
-7% -$482K
APLS
16
DELISTED
Apellis Pharmaceuticals
APLS
$6.22M 2.06%
137,616
ARWR icon
17
Arrowhead Research
ARWR
$12B
$6.18M 2.05%
175,393
-7,324
-4% -$276K
ALBO
18
DELISTED
Albireo Pharma Inc
ALBO
$5.96M 1.98%
300,252
-51,553
-15% -$1.36M
ROKU icon
19
Roku
ROKU
$23.4B
$5.37M 1.78%
65,410
+2,000
+3% +$194K
CRWD icon
20
CrowdStrike
CRWD
$224B
$5.01M 1.66%
118,800
RBLX icon
21
Roblox
RBLX
$27.5B
$4.78M 1.58%
145,500
ESTC icon
22
Elastic
ESTC
$10.4B
$4.46M 1.48%
65,957
+5,000
+8% +$364K
PRQR icon
23
ProQR Therapeutics
PRQR
$323M
$4.16M 1.38%
5,344,446
+100,000
+2% +$74.5K
OPAD icon
24
PUT
Offerpad Solutions
OPAD
$21.3M
$3.88M 1.28%
24
+3
+14% +$2.01K
CRM icon
25
Salesforce
CRM
$211B
$3.38M 1.12%
20,450
+16,641
+437% +$2.94M

Similar funds

Privium Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Privium Fund Management held 317 positions worth $302M, down 33% from $452M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Privium Fund Management withdrew a net $16.4M in Q2 2022, closing 64 positions and reducing 65 holdings. Its most notable exit was Royalty Pharma, an estimated $9.48M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Privium Fund Management opened a new position in Microsoft worth $2.06M.

  • Privium Fund Management's largest Q2 2022 buy was Microsoft: 8,000 shares worth $2.06M.
  • Privium Fund Management added most to Snowflake in Q2 2022, an estimated $3.72M increase.
  • Privium Fund Management's biggest Q2 2022 reduction was argenx, cutting an estimated $4.12M.
  • Privium Fund Management fully exited Royalty Pharma in Q2 2022, selling an estimated $9.48M.
  • Privium Fund Management's ten largest holdings make up 50% of its $302M portfolio in Q2 2022.
  • Privium Fund Management opened 38 new positions and closed 64 in Q2 2022.
  • Privium Fund Management's portfolio value fell 33% quarter-over-quarter to $302M.

Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.